• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST PST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 07671687019
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/02/2023
Event Type  malfunction  
Manufacturer Narrative
Two test strip lots were used with the coaguchek inrange system: 70302122, expiration date 31-oct-2024 and 71519012, expiration date 31-dec-2024.It is not known which test strip lot was used for which test.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
 
Event Description
The initial reporter complained of discrepant inr results for 1 patient tested with a coaguchek inrange meter and a coaguchek xs plus meter compared to an unknown laboratory method.This medwatch will cover the coaguchek inrange system.Refer to medwatch with a1 patient identifier (b)(6) for information on the coaguchek xs plus system.On (b)(6) 2023 the result from the inrange meter was 4.2 inr.The result from the xs plus meter was 4.1 inr.The result from the laboratory from a sample drawn at the same time was 2.1 inr.On (b)(6) 2023 the result from the inrange meter was 4.8 inr.The result from the xs plus meter was 4.5 inr.The result from the laboratory from a sample drawn at the same time was 3.5 inr.On (b)(6) 2023 the result from the inrange meter was 4.1 inr.The result from the xs plus meter was 3.9 inr.The result from the laboratory from a sample drawn at the same time was 2.9 inr.The patient¿s therapeutic range was not provided.
 
Manufacturer Narrative
Section d, device identification was updated.Relevant fields of sections d and g were updated.The coaguchek inrange meter serial number was (b)(6).The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST PST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250-0457
MDR Report Key17876226
MDR Text Key324982259
Report Number1823260-2023-03195
Device Sequence Number1
Product Code GJS
Combination Product (y/n)Y
Reporter Country CodeUK
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 10/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07671687019
Device Lot Number70302122, 71519012
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/07/2023
Initial Date FDA Received10/05/2023
Supplement Dates Manufacturer Received10/05/2023
Supplement Dates FDA Received10/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
OMEPRAZOLE.; PREDNISOLONE.
-
-